A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- N/A
Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA